Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 10:15 am Purchase | 2025-03-31 | 13G | Petros Pharmaceuticals, Inc. PTPI | Iroquois Capital Management, LLC | 5,939,954 9.990% | 5,838,871 (+5776.29%) | Filing History |
| 2025-02-26 09:16 am Purchase | 2025-02-17 | 13G | Petros Pharmaceuticals, Inc. PTPI | Iroquois Capital Management, LLC | 101,083 9.990% | 101,083 (New Position) | Filing History |
| 2025-02-13 1:44 pm Sale | 2024-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI | Ayrton Capital LLC | 26,305 6.200% | -612 (-2.27%) | Filing History |
| 2024-11-14 5:17 pm Purchase | 2024-09-30 | 13G | Petros Pharmaceuticals, Inc. PTPI | Ayrton Capital LLC | 26,916 6.500% | 17,145 (+175.45%) | Filing History |
| 2024-11-13 11:14 am Purchase | 2024-09-30 | 13G | Petros Pharmaceuticals, Inc. PTPI | Mitchell P. Kopin | 20,182 4.990% | 13,991 (+226.00%) | Filing History |
| 2024-02-14 3:38 pm Purchase | 2023-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI | Ayrton Capital LLC | 9,772 9.900% | 9,772 (New Position) | Filing History |
| 2024-02-06 10:23 am Sale | 2023-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI | Mitchell P. Kopin | 6,191 6.600% | -495 (-7.40%) | Filing History |
| 2023-02-08 06:08 am Purchase | 2022-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI | Mitchell P. Kopin | 6,686 7.600% | 6,686 (New Position) | Filing History |
| 2022-02-28 4:30 pm Purchase | 2021-12-02 | 13D | Petros Pharmaceuticals, Inc. PTPI | SHULMAN JOHN D | 31,524 34.470% | 4,545 (+16.85%) | Filing History |
| 2022-02-23 4:25 pm Purchase | 2021-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI | Iroquois Capital Management, LLC | 4,777 4.990% | 1,880 (+64.88%) | Filing History |
| 2022-02-11 07:54 am Purchase | 2021-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI | Mitchell P. Kopin | 6,407 7.200% | 4,091 (+176.62%) | Filing History |
| 2022-02-10 2:46 pm Sale | 2021-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI | HAYWOOD GEORGE WEAVER | 180 0.200% | -3,885 (-95.57%) | Filing History |
| 2021-10-27 09:47 am Purchase | 2021-10-19 | 13G | Petros Pharmaceuticals, Inc. PTPI | HAYWOOD GEORGE WEAVER | 4,065 7.600% | 4,065 (New Position) | Filing History |
| 2021-10-22 06:51 am Purchase | 2021-10-18 | 13G | Petros Pharmaceuticals, Inc. PTPI | Iroquois Capital Management, LLC | 2,897 9.990% | 2,897 (New Position) | Filing History |
| 2021-10-20 5:25 pm Purchase | 2021-10-18 | 13D | Petros Pharmaceuticals, Inc. PTPI | SHULMAN JOHN D | 26,978 51.190% | 13,394 (+98.61%) | Filing History |
| 2021-01-29 06:14 am Unchanged | 2020-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI | Mitchell P. Kopin | 2,316 5.700% | 0 (Unchanged) | Filing History |
| 2021-01-20 4:26 pm Purchase | 2020-12-01 | 13G | Petros Pharmaceuticals, Inc. PTPI | Mitchell P. Kopin | 2,316 5.700% | 2,316 (New Position) | Filing History |
| 2020-12-11 5:26 pm Purchase | 2020-12-01 | 13D | Petros Pharmaceuticals, Inc. PTPI | SHULMAN JOHN D | 13,584 34.900% | 13,584 (New Position) | Filing History |